The Use of Proton Pump Inhibitors Among Older Adults with Intellectual Disability: A Cross Sectional Observational Study

Overview

Journal Saudi Pharm J

Specialty Pharmacy

Date 2018 Nov 13

PMID 30416357

Citations 5

Authors

Hadiah Almutairi

Maire ODwyer

Mary McCarron

Philip McCallion

Martin C Henman

Affiliations

Soon will be listed here.

Abstract

Background: Older people with Intellectual Disability (ID) have a high prevalence of gastrointestinal conditions such as Gastro-Oesophageal Reflux Disease (GORD). However, despite this, information about treatment, in particular the use of Proton Pump Inhibitors (PPIs), in this population is sparse and limited.

Objective: To investigate the prevalence and pattern of PPI use among older people with ID.

Method: Data on PPI use and key demographics was analysed from Wave 2 (2013/2014) of IDS-TILDA, a nationally representative longitudinal study of 677 participants aged 40 years and above in Ireland. Descriptive statistics, bivariate analyses and binary logistic regression were carried out.

Results: Just over a quarter, 27.9% (n = 189), of participants reported use of PPIs, and 53.4% (n = 101) were female. The largest proportion of PPI users (53.4%) were aged between 50 and 64 yrs. Most of the PPIs were used in maximum doses (66.7%). However only 43.9% of PPI users had an indication for PPI use (GORD, stomach ulcer or/and an NSAID use), and further 13.2% were also taking an antiplatelet agent. Use among those in residential care homes (54.3%) was much higher than for those living independently or with family (7%). PPI use among those who have severe/profound ID was 25% higher than those with mild ID. Information about the length of PPI use was missing for 31.2%, but of those with data, just over half recorded using the PPIs for more than a year. Apart from an indication, the factors associated with PPI use were older ages (≥50 years), severe/profound level of ID.

Conclusion: PPI use among older people with intellectual disability is prevalent and frequently long term, often without a clear indication. PPI use especially among those with severe/profound ID and those who live in residential care homes, could predispose these individuals to additional comorbidities and in order to avoid inappropriate long term of use regular review is required.

Citing Articles

Prevalence and Factors Associated With Proton Pump Inhibitors (PPIs) Use: A Cross-Sectional Study of PERSIAN Guilan Cohort Study.

Roudgar S, Joukar F, Mojtahedi K, Maroufizadeh S, Naghipour M, Mansour-Ghanaei F Health Sci Rep. 2025; 8(2):e70494.

PMID: 39980829 PMC: 11840240. DOI: 10.1002/hsr2.70494.

Proton pump inhibitors associated with an increased risk of mortality in elderly: a systematic review and meta-analysis.

Song H, Seo H, Jiang X, Jeon N, Lee Y, Ha I Eur J Clin Pharmacol. 2023; 80(3):367-382.

PMID: 38147074 DOI: 10.1007/s00228-023-03606-0.

Proton pump inhibitor prescribing patterns and utilization: A retrospective chart review analysis.

Algabbani A, Alangari A Saudi Pharm J. 2023; 31(12):101841.

PMID: 37961073 PMC: 10638047. DOI: 10.1016/j.jsps.2023.101841.

Adverse Effects in Patients with Intellectual and Developmental Disabilities Hospitalized at the University Clinical Hospital.

Alonso-Sardon M, Saez-Lorenzo M, Chamorro A, Fernandez-Martin L, Iglesias-DE-Sena H, Gonzalez-Nunez V J Pers Med. 2022; 12(11).

PMID: 36422074 PMC: 9698866. DOI: 10.3390/jpm12111898.

Nature and extent of intellectual disability nursing research in Ireland: a scoping review to inform health and health service research.

Doody O, Bailey M, Hennessy T BMJ Open. 2021; 11(10):e051858.

PMID: 34615681 PMC: 8496393. DOI: 10.1136/bmjopen-2021-051858.

References

Hermans H, Evenhuis H . Multimorbidity in older adults with intellectual disabilities. Res Dev Disabil. 2014; 35(4):776-83. DOI: 10.1016/j.ridd.2014.01.022. View

Pace F, Tonini M, Pallotta S, MOLTENI P, Porro G . Systematic review: maintenance treatment of gastro-oesophageal reflux disease with proton pump inhibitors taken 'on-demand'. Aliment Pharmacol Ther. 2007; 26(2):195-204. DOI: 10.1111/j.1365-2036.2007.03381.x. View

Nishtala P, Soo L . Proton pump inhibitors utilisation in older people in New Zealand from 2005 to 2013. Intern Med J. 2015; 45(6):624-9. DOI: 10.1111/imj.12757. View

Jarchow-Macdonald A, Mangoni A . Prescribing patterns of proton pump inhibitors in older hospitalized patients in a Scottish health board. Geriatr Gerontol Int. 2013; 13(4):1002-9. DOI: 10.1111/ggi.12047. View

Peklar J, Kos M, ODwyer M, McCarron M, McCallion P, Kenny R . Medication and supplement use in older people with and without intellectual disability: An observational, cross-sectional study. PLoS One. 2017; 12(9):e0184390. PMC: 5587307. DOI: 10.1371/journal.pone.0184390. View

Fulton M, Allen E . Polypharmacy in the elderly: a literature review. J Am Acad Nurse Pract. 2005; 17(4):123-32. DOI: 10.1111/j.1041-2972.2005.0020.x. View

Shekelle P, MacLean C, Morton S, Wenger N . Acove quality indicators. Ann Intern Med. 2001; 135(8 Pt 2):653-67. DOI: 10.7326/0003-4819-135-8_part_2-200110161-00004. View

Freedberg D, Kim L, Yang Y . The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association. Gastroenterology. 2017; 152(4):706-715. DOI: 10.1053/j.gastro.2017.01.031. View

McQuaid K, Laine L . Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials. Am J Med. 2006; 119(8):624-38. DOI: 10.1016/j.amjmed.2005.10.039. View

10.

Sandberg M, Ahlstrom G, Axmon A, Kristensson J . Somatic healthcare utilisation patterns among older people with intellectual disability: an 11-year register study. BMC Health Serv Res. 2016; 16(1):642. PMC: 5103402. DOI: 10.1186/s12913-016-1880-x. View

11.

Rane P, Guha S, Chatterjee S, Aparasu R . Prevalence and predictors of non-evidence based proton pump inhibitor use among elderly nursing home residents in the US. Res Social Adm Pharm. 2016; 13(2):358-363. DOI: 10.1016/j.sapharm.2016.02.012. View

12.

Pasina L, Nobili A, Tettamanti M, Salerno F, Corrao S, Marengoni A . Prevalence and appropriateness of drug prescriptions for peptic ulcer and gastro-esophageal reflux disease in a cohort of hospitalized elderly. Eur J Intern Med. 2011; 22(2):205-10. DOI: 10.1016/j.ejim.2010.11.009. View

13.

Yadlapati R, Kahrilas P . When is proton pump inhibitor use appropriate?. BMC Med. 2017; 15(1):36. PMC: 5319103. DOI: 10.1186/s12916-017-0804-x. View

14.

Heslop P, Glover G . Mortality of People with Intellectual Disabilities in England: A Comparison of Data from Existing Sources. J Appl Res Intellect Disabil. 2015; 28(5):414-22. DOI: 10.1111/jar.12192. View

15.

Moriarty F, Hardy C, Bennett K, Smith S, Fahey T . Trends and interaction of polypharmacy and potentially inappropriate prescribing in primary care over 15 years in Ireland: a repeated cross-sectional study. BMJ Open. 2015; 5(9):e008656. PMC: 4577876. DOI: 10.1136/bmjopen-2015-008656. View

16.

de Veer A, Bos J, Niezen-de Boer R, Bohmer C, Francke A . Symptoms of gastroesophageal reflux disease in severely mentally retarded people: a systematic review. BMC Gastroenterol. 2008; 8:23. PMC: 2435531. DOI: 10.1186/1471-230X-8-23. View

17.

Wallace R, Schluter P, Webb P . Recurrence of Helicobacter pylori infection in adults with intellectual disability. Intern Med J. 2004; 34(3):132-3. DOI: 10.1111/j.1444-0903.2004.00505.x. View

18.

Leonard J, Marshall J, Moayyedi P . Systematic review of the risk of enteric infection in patients taking acid suppression. Am J Gastroenterol. 2007; 102(9):2047-56. DOI: 10.1111/j.1572-0241.2007.01275.x. View

19.

. American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2015; 63(11):2227-46. DOI: 10.1111/jgs.13702. View

20.

George C, Korc B, Ross J . Appropriate proton pump inhibitor use among older adults: a retrospective chart review. Am J Geriatr Pharmacother. 2009; 6(5):249-54. DOI: 10.1016/j.amjopharm.2008.12.001. View